CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-27 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −2,754 | $196.70 | $542K | 193,071 |
| 2022-02-27 | Gebski Christine See Remarks | Shares withheld for taxes | −462 | $196.70 | $91K | 35,025 |
| 2022-02-24 | Hunt Anthony Chief Executive Officer | Grant or award | +15,855 | 196,995 | ||
| 2022-02-24 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −1,170 | $189.21 | $221K | 195,825 |
| 2022-02-24 | Hunt Anthony Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +20,307 | 20,307 | ||
| 2022-02-24 | KURIYEL RALF Senior VP, R&D | Grant or award | +2,126 | 19,310 | ||
| 2022-02-24 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −188 | $189.21 | $36K | 19,122 |
| 2022-02-24 | KURIYEL RALF Senior VP, R&D | Grant or award · Stock Option (Right to Buy) | +2,723 | 2,723 | ||
| 2022-02-24 | Snodgres Jon Chief Financial Officer | Grant or award | +3,443 | 33,904 | ||
| 2022-02-24 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −269 | $189.21 | $51K | 33,635 |
| 2022-02-24 | Snodgres Jon Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +4,410 | 4,410 | ||
| 2022-02-24 | Gebski Christine See Remarks | Grant or award | +2,124 | 35,668 | ||
| 2022-02-24 | Gebski Christine See Remarks | Shares withheld for taxes | −181 | $189.21 | $34K | 35,487 |
| 2022-02-24 | Gebski Christine See Remarks | Grant or award · Stock Option (Right to Buy) | +2,721 | 2,721 | ||
| 2022-02-24 | Bylund James Chief Operating Officer | Grant or award | +3,366 | 10,256 | ||
| 2022-02-24 | Bylund James Chief Operating Officer | Shares withheld for taxes | −188 | $189.21 | $36K | 10,068 |
| 2022-02-24 | Bylund James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +4,312 | 4,312 | ||
| 2022-02-17 | Bylund James Chief Operating Officer | Grant or award | +900 | 7,224 | ||
| 2022-02-17 | Bylund James Chief Operating Officer | Shares withheld for taxes | −334 | $182.42 | $61K | 6,890 |
| 2022-02-17 | KURIYEL RALF Senior VP, R&D | Grant or award | +450 | 17,359 |
Page 22 of 23 · 455 trades